Mobius Therapeutics, LLC™
Dedicated to helping glaucoma surgeons and their patients.
The use of mitomycin in ophthalmic surgery has become common, as evidenced by publications, clinical trials, and supporting data. Mitosol (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use reinvents mitomycin for ophthalmology.
• Assured dosing, potency, and sterility.
• Room temperature, ambient light storage.
• Extended shelf life.
• Strictly minimized contact potential.
• Elimination of aerosolization.
With more than a century of combined experience in ophthalmology, the core management team of Mobius brings rock solid management and unmatched strategic vision to ophthalmic surgery. Each member of the sales team holds more than 20 years of direct clinical experience in the ophthalmic surgery field. Mobius Therapeutics aims to serve its customers, educate allied health, and contribute to the cause of high quality, affordable vision care.
WMI-023 Rev 01/2018